Jaguar Health announced positive findings from exploratory surveys of dog owners and veterinary oncologists supporting the commercial opportunity for Neonorm Dog, a new plant-based product designed to support normal stool consistency and GI fluid balance in dogs. In a survey of 33 veterinary oncologists, nearly 90% viewed the Neonorm Dog concept as clinically relevant and almost 80% indicated they would be likely to recommend it for selected canine oncology patients. A separate survey of 18 dog owners found that 83% found the concept very or extremely appealing and 94% indicated they would definitely or probably purchase the product. Jaguar expects to make Neonorm Dog available through select online and animal health retail channels, including Amazon and Chewy, as part of a planned launch to broaden its commercial footprint in the companion animal market.
Jaguar Animal Health IncPositive survey results and planned launch of Neonorm Dog indicate strong potential demand for Jaguar's product.
Amazon.com Inc